We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SAN:BMEBanco Santander, S.A. Analysis

Data as of 2026-03-09 - not real-time

$11.20

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Banco Santander posted its strongest annual profit in recent history, reinforcing the strength of its core banking franchise and supporting a robust dividend payout. The stock trades at a price‑to‑earnings multiple comfortably below the sector average, while offering a dividend yield that ranks attractively among peers. Technical signals are mixed: momentum indicators have turned bearish, yet the price remains above a key support zone and below a clear resistance ceiling, suggesting limited upside in the very short run. Volume is trending higher, indicating continued investor interest despite elevated price swings. The recent acquisition of a U.S. lender expands the bank’s geographic footprint and may diversify earnings, though integration risk remains. Overall, the valuation appears attractive relative to fundamentals, but heightened volatility and a modest beta warrant caution.
The dividend appears sustainable given a modest payout ratio and a strong cash position, offset by a sizable debt load that is typical for large banks. Regulatory and geographic exposure are moderate, with the bank well‑positioned in a stable European market while pursuing growth in the United States. Investors should weigh the blend of solid earnings, attractive yield, and valuation upside against the near‑term technical weakness and broader market risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • bearish momentum from MACD and RSI approaching oversold territory
  • price sitting just above a recent support level
  • elevated short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • valuation discount relative to industry peers
  • strong earnings record and sustainable dividend
  • strategic acquisition expanding U.S. presence

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • solid capital base and consistent profitability
  • attractive dividend yield with low payout ratio
  • diversified business model across retail, corporate and wealth segments

Key Metrics & Analysis

Financial Health

Revenue Growth-6.40%
Profit Margin30.11%
P/E Ratio11.5
ROE12.69%
ROA0.75%
P/B Ratio1.4
Op. Cash Flow$-14835000320
Industry P/E17.4

Technical Analysis

TrendNeutral
RSI40.0
Support$10.65
Resistance$13.24
MA 20$12.18
MA 50$12.21
MA 200$10.22
MACDBearish
VolumeIncreasing
Fear & Greed Index100

Valuation

Target Price$10.74
Upside/Downside-4.15%
GradeUndervalued
TypeValue
Dividend Yield2.53%

Risk Assessment

Beta1.08
Volatility51.54%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.